Literature DB >> 2261838

Diabetic cardiomyopathy.

F S Fein1.   

Abstract

The purpose of this article was to review the clinical and experimental features of diabetic cardiomyopathy, with particular relevance to the Black population. One hundred thirty-seven studies were identified, of which 57 were selected as references for this article. Diabetes is associated with the development of cardiomyopathy, independent of coronary atherosclerosis. Pathological studies show myocardial hypertrophy and fibrosis; microvascular pathology is also present, but all of these pathological findings have an uncertain relationship to myocardial failure. Hemodynamic findings of both congestive and restrictive cardiomyopathy have been described. Noninvasive studies revealed abnormal systolic and diastolic function in many diabetic subjects, particularly in the presence of diabetic complications and/or hypertension. Experimental studies have focused on the mildly diabetic dog and the severely diabetic rat. One year of diabetes in dogs resulted in decreased left ventricular compliance and increased interstitial connective tissue. Studies in the diabetic rat showed a marked slowing of contraction and relaxation. Chronic insulin therapy reversed the changes in the rat model. Combining hypertension with diabetes in the rat resulted in increased myocardial and coronary microvascular pathology and greater changes in isolated muscle function, electrophysiology, and contractile protein biochemistry. Many hypertensive diabetic rats died spontaneously, showing signs of congestive heart failure. Diabetic cardiomyopathy is a significant cause of heart failure in diabetic subjects and occurs more frequently in those with microvascular complications and/or hypertension. Clinical studies are needed to clarify the natural history of this disorder, focusing on the benefits of tight control of hyperglycemia and treatment of associated hypertension. Experimental studies will clarify the pathophysiology and contribute to improved therapy. The high prevalence of diabetes and hypertension in Blacks makes these considerations especially relevant to this population.

Entities:  

Mesh:

Year:  1990        PMID: 2261838     DOI: 10.2337/diacare.13.11.1169

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  35 in total

1.  [Aerobic and strength training in patients with diabetes mellitus type 2 and heart failure].

Authors:  D Niederseer; J Niebauer
Journal:  Herz       Date:  2012-08       Impact factor: 1.443

2.  Propionyl-L-carnitine effects on postischemic recovery of heart function and substrate oxidation in the diabetic rat.

Authors:  T L Broderick; W Driedzic; D J Paulson
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

3.  Effectiveness of cardiac resynchronization therapy in diabetic patients with ischemic and nonischemic cardiomyopathy.

Authors:  Jenie George; Alon Barsheshet; Arthur J Moss; David Martin; Gregory Ouellet; Scott McNitt; Ilan Goldenberg
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-01       Impact factor: 1.468

4.  Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.

Authors:  Mohanraj Rajesh; Sándor Bátkai; Malek Kechrid; Partha Mukhopadhyay; Wen-Shin Lee; Béla Horváth; Eileen Holovac; Resat Cinar; Lucas Liaudet; Ken Mackie; György Haskó; Pál Pacher
Journal:  Diabetes       Date:  2012-02-07       Impact factor: 9.461

5.  MicroRNA-34a regulates high glucose-induced apoptosis in H9c2 cardiomyocytes.

Authors:  Fang Zhao; Bo Li; Yin-Zhi Wei; Bin Zhou; Han Wang; Ming Chen; Xue-Dong Gan; Zhao-Hui Wang; Shi-Xi Xiong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

Review 6.  Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.

Authors:  Pál Pacher; Irina G Obrosova; Jon G Mabley; Csaba Szabó
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

Review 7.  Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.

Authors:  Rui Guo; Sreejayan Nair
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-24       Impact factor: 5.187

8.  Intense exercise training induces adaptation in expression and responsiveness of cardiac β-adrenoceptors in diabetic rats.

Authors:  Solène Le Douairon Lahaye; Arlette Gratas-Delamarche; Ludivine Malardé; Sophie Vincent; Mohamed Sami Zguira; Sophie Lemoine Morel; Paul Delamarche; Hassane Zouhal; François Carré; Françoise Rannou Bekono
Journal:  Cardiovasc Diabetol       Date:  2010-11-05       Impact factor: 9.951

Review 9.  Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.

Authors:  Zoltán V Varga; Zoltán Giricz; Lucas Liaudet; György Haskó; Peter Ferdinandy; Pál Pacher
Journal:  Biochim Biophys Acta       Date:  2014-07-02

10.  Exercise training initiated after the onset of diabetes preserves myocardial function: effects on expression of beta-adrenoceptors.

Authors:  Keshore R Bidasee; Hong Zheng; Chun-Hong Shao; Sheeva K Parbhu; George J Rozanski; Kaushik P Patel
Journal:  J Appl Physiol (1985)       Date:  2008-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.